Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

PURPOSE Variables used to build up the International Index for aggressive lymphomas (age, performance status, stage, extranodal involvement, and lactic dehydrogenase [LDH]) are also important in low-grade lymphoma. To assess the prognostic value of this index in low-grade lymphoma, we have applied it to a series of 125 patients. PATIENTS AND METHODS One hundred twenty-five patients with low-grade lymphoma who were diagnosed at a single institution over a 20-year period and treated with standard chemotherapy were studied. End points of the study were response to therapy and survival according to the International Index. In addition to the International Index, main initial and evolutive variables were evaluated. Univariate and multivariate methods were used. RESULTS After applying the International Index, the patients divided into four risk groups: low (36% of cases), low-intermediate (32%), high-intermediate (20.8%), and high (11.2%), with complete response (CR) rates in the four groups being 60%, 35%, 23%, and 21%, respectively. Ten-year overall survival rates for the risk groups were as follows: low, 73.6%; low-intermediate, 45.2%; high-intermediate, 53.5%; and high, 0% (P < .001). When the International Index was included in a multivariate analysis, along with the main initial variables, International Index (P < .001) and sex (male, worse) (P = .038) were the only parameters related to survival. When response to therapy was also included, achievement of CR (P < .0001) and International Index (P < .001) were the most important factors. In patients who achieved a CR, the International Index was the only parameter related to survival (P = .051). The results were the same when the International Index was applied to the subset of 107 patients with follicular lymphoma. CONCLUSION In this study, the International Index has been found to be an important prognostic tool in low-grade lymphomas. Such an index could be used to predict prognosis not only in aggressive, but also in low-grade lymphomas.

[1]  F. Cabanillas,et al.  Nodular malignant lymphomas. Factors affecting complete response rate and survival , 1979, Cancer.

[2]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[3]  V. Devita,et al.  Malignant lymphoma II. Prognostic factors and response to treatment of 473 patients at the national cancer institute , 1982, Cancer.

[4]  R. Prescott,et al.  Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party. , 1993, Leukemia & lymphoma.

[5]  Angela C. Dawson,et al.  The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  B. Coiffier.  How should prognostic factors influence therapy in follicular lymphomas? , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Tucker,et al.  Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma , 1991 .

[8]  W. Velasquez,et al.  Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. , 1991 .

[10]  O. Kucuk,et al.  Effect of the degree of nodularity on the survival of patients with nodular lymphomas. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C C Bird,et al.  Prognostic indicators in centroblastic-centrocytic lymphoma. , 1988, Journal of clinical pathology.

[12]  T. Lister,et al.  Follicular lymphoma: prognostic factors for response and survival. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Berger,et al.  Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  M. Pike,et al.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. , 1973, Biometrics.

[15]  T. Lister,et al.  Management of follicular lymphoma , 1991, Current opinion in oncology.

[16]  W. Velasquez,et al.  Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.